Free Trial

Stevanato Group (NYSE:STVN) Shares Gap Down - Here's Why

Stevanato Group logo with Medical background

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at €22.08 ($25.38), but opened at €21.40 ($24.60). Stevanato Group shares last traded at €20.98 ($24.11), with a volume of 56,070 shares changing hands.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on STVN shares. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. UBS Group decreased their price target on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research note on Friday, March 7th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of €25.70 ($29.54).

View Our Latest Analysis on STVN

Stevanato Group Trading Down 0.2 %

The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The stock has a market capitalization of $6.56 billion, a P/E ratio of 46.06, a price-to-earnings-growth ratio of 7.18 and a beta of 0.52. The stock has a 50-day moving average price of €20.59 and a two-hundred day moving average price of €20.69.

Stevanato Group (NYSE:STVN - Get Free Report) last released its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.23) earnings per share for the quarter, meeting the consensus estimate of €0.20 ($0.23). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business had revenue of €352.68 million for the quarter, compared to analysts' expectations of €346.26 million. On average, research analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Institutional Trading of Stevanato Group

Several large investors have recently bought and sold shares of the company. M&T Bank Corp bought a new position in shares of Stevanato Group in the 4th quarter worth approximately $572,000. Mutual of America Capital Management LLC bought a new position in Stevanato Group in the fourth quarter worth $13,848,000. Advantage Alpha Capital Partners LP lifted its position in Stevanato Group by 27.3% during the fourth quarter. Advantage Alpha Capital Partners LP now owns 293,865 shares of the company's stock valued at $6,403,000 after buying an additional 63,041 shares during the period. Allianz SE bought a new stake in shares of Stevanato Group during the 4th quarter valued at $748,000. Finally, Zions Bancorporation N.A. grew its position in shares of Stevanato Group by 29.7% in the 4th quarter. Zions Bancorporation N.A. now owns 68,017 shares of the company's stock worth $1,482,000 after buying an additional 15,555 shares during the period.

About Stevanato Group

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Recommended Stories

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines